EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma

Charles Marcus

Cancers · 27.09.2025 · 17 (19) · 3140

DOI: 10.3390/cancers17193140 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.09.2025. Verfasst von Charles Marcus. Beteiligte Einrichtung: Division of Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck cancers account for approximately 3.0% of all new cancer diagnoses. 18F-FDG PET/CT plays an important role in the initial staging of these cancers, especially in the detection of nodal and distant metastatic disease, outperforming conventional imaging techniques. It helps identify occult primary tumors and synchronous second primary malignancies. PET/CT findings can lead to treatment plan alterations both in surgical and primary or adjuvant chemoradiation plans. High negative predictive value at treatment response assessment provides valuable prognostic implications. PET/CT can predict outcomes at baseline and during or after treatment.

Schlagwörter

Stichwörter der Autor:innen

PETPET/CTPET/MRIdisease recurrencefollow-uphead and neck cancerhead and neck squamous cell carcinomalarynxoral cavityoropharynxstagingtreatment planningtreatment response

Autor:innen und Institutionen

  • Division of Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Division of Nuclear Medicine, Department of Radiology, Emory University School of Medicine, Atlanta, GA 30322, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Marcus, C. (2025). Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma. Cancers, 17(19), 3140. https://doi.org/10.3390/cancers17193140

Vancouver

Marcus C. Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma. Cancers. 2025;17(19):3140. doi:10.3390/cancers17193140

BibTeX
@article{Marcus2025,
  author = {Marcus, Charles},
  title = {Use of FDG PET for Staging and Re-Staging of Head and Neck Squamous Cell Carcinoma},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {19},
  pages = {3140},
  doi = {10.3390/cancers17193140}
}
Kostenlos starten →